Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

NCT02756247

Conditions
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

NCT03036904

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Weill Cornell Medicine New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Lenalidomide Monotherapy in R/R DLBCL

NCT04150328

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • MorphoSys Research Site Rochester, Minnesota, United States
  • MorphoSys Research Site St Louis, Missouri, United States
  • MorphoSys Research Site Manhasset, New York, United States
  • MorphoSys Research Site New York, United States
View all 57 locations
View Trial Details
Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New Orleans, Louisiana, United States
View Trial Details
Completed

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

NCT03630159

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Emory University School of Medicine SC CTL019 Atlanta, Georgia, United States
  • University of Chicago Medical Center Hematology and Oncology Chicago, Illinois, United States
  • University of Kansas Hospital and Medical Center U of Kansas Cancer Center Kansas City, Kansas, United States
  • Novartis Investigative Site Vienna, Austria
View Trial Details
Completed

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

NCT01516593

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +16 more
Locations
  • Oncologia Medica A - Centro di Riferimento Oncologico Aviano (PN), Italy
  • Ematologia - A.O. Spedali Civili Brescia, Italy
  • Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Milan, Italy
  • S.C. Oncologia Medica - Ospedale San Paolo Milan, Italy
View Trial Details

Related conditions